TFF3 facilitates dormancy of anti-estrogen treated ER+ mammary carcinoma
Abstract Background Tumor dormancy is a substantial clinical obstacle in treatment of estrogen receptor positive mammary carcinoma (ER+MC), contributing to drug resistance, metastatic outgrowth, relapse, and consequent mortality. Methods Preclinical models mimicking clinical anti-estrogen-induced ER...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Portfolio
2025-02-01
|
| シリーズ: | Communications Medicine |
| オンライン･アクセス: | https://doi.org/10.1038/s43856-024-00710-9 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|